Neuralink tested a brain implant approach that threads electrodes through the dura without cutting it open. The company says ...

A less invasive brain-computer interface is being developed to help people with impaired speech, including ALS, communicate.

Oral PrimeC for ALS significantly reduced toxic TDP-43 protein levels in a Phase 2b trial. PrimeC also slowed functional decline and extended survival by about 15 months. The treatment was well ...

Whole-body MRI (WB-MRI) may improve ALS diagnostic certainty. WB-MRI assesses muscle swelling (edema) as a marker for lower ...

Former Tennessee Titans football player Chris Johnson is sharing his diagnosis with ALS at age 39. The ex-NFL player says he hopes to raise awareness and encourage testing for the rare disease.

Having resilience is so important to me that I’ve written several columns about it. I believe resilience — the ability to cope with and survive change — is a skill ALS patients should hone to navigate ...

TRCN-1023, an experimental treatment for ALS, aims to restore UNC13A function. It is designed to improve communication between nerves and muscles. Global Phase 1/2 clinical trials are underway to ...

A clinical trial in Europe is testing the safety and pharmacological properties of LTX-002 as a potential treatment for ALS. The new therapy targets dysregulated fat metabolism, a key contributor to ...

AMX0114, an investigational therapy for ALS, showed safety and good tolerability at its lowest dose in a first-in-human clinical trial. Developer Amylyx is now advancing that trial, called LUMINA, to ...

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by the progressive loss of motor neurons, nerve cells that control the voluntary muscles. This leads to overall ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that results in the death of nerve cells called motor neurons in the brain and spinal cord. These neurons control voluntary ...